arrow
N

Natalina Elliott

University of Oxford
H指数:11
被引数:982

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The fetal specific gene LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A-AFF1 infant leukemia

胎特异性基因LIN28B对人类胎儿B淋巴细胞生成和KMT2A-AFF1婴儿白血病的起始至关重要

Blood
IF23.1
2026-06-020
OA
Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia

现成的双CAR-iNKT细胞免疫疗法可清除髓内和软脑膜高风险KMT2A重排白血病

Blood
IF23.1
2025-09-040
OAAI
Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients

增强子异质性在急性淋巴细胞白血病中驱动患者间差异基因表达

Blood
IF23.1
2025-07-310
OAAI
PROM1/CD133 MARKS A PROLIFERATIVE STEM CELL LIKE POPULATION OF BLASTS IN KMT2A REARRANGED INFANT ALL

PROM1/CD133标记了KMT2A重排婴儿急性淋巴细胞白血病中的一种增殖性类干细胞blast群体。

2025-07-050
OAAI
Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome

Down综合征儿童中前白血病性体细胞GATA1突变的临床意义

Blood
IF23.1
2025-06-270
OA
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
2022-11-0957
OAAI
Accelerated epigenetic aging in newborns with Down syndrome
2022-06-0618
OAAI
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program
2021-11-2528
OAAI
Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia
2021-01-0827
OAAI
H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
LEUKEMIA
IF13.4
2020-04-0240
OAAI